Pharmaceutical composition for preventing or treating dry eyes
US10913788B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 2015 |
| Grant date | Feb 9, 2021 |
| Priority date | — |
| Expiry date | Jul 16, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/39
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition for preventing or treating dry eye, the pharmaceutical composition including, as an active component, a novel peptide is disclosed, wherein it is confirmed that the peptide has effects on improving tear production and corneal surface smoothness for dry eyes induced by desiccation stress and suppressing detachment of corneal epithelial cells, reduction in conjunctival goblet cells, and generation of inflammatory factors, thereby applying a composition including the peptide as an active component to the pharmaceutical composition for preventing or treating dry eye.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.